Learning Objectives:

1. Define ways to assess risk of significant liver disease in patients suspected of having nonalcoholic fatty liver disease.

2. Articulate ways to  identify liver disease in patients suspected of having nonalcoholic fatty liver disease

3. Describe  management of  liver disease in patients suspected of having nonalcoholic fatty liver disease.

Session date: 
01/15/2021 - 8:00am to 9:00am CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Michael Charlton, MBBS, FRCP